Showing results (301-310 of 409) with videos related to
Sort By:
Pageof 41
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 4, 2017
Intensity-based dual model method for generation of synthetic CT images from standard T2-weighted MR images - Generalized technique for four different MR scannersLauri Koivula, Mika Kapanen, Tiina Seppälä, et al.Medical Physics|December 23, 2020
Toward real-time verification for MLC tracking treatments using time-resolved EPID imagingBenjamin J Zwan, Vincent Caillet, Jeremy T Booth, et al.Histopathology|May 8, 2026
Clinicopathologic evaluation of dedifferentiated liposarcoma lacking MDM2 amplificationCharlotte I Wang, Soma Jobbagy, Anne B Giersch, et al.Journal of Molecular Endocrinology|December 11, 2003
Novel dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1(7-36)amide have preserved biological activities in vitro conferring improved glucose-lowering action in vivoB D Green, V A Gault, M H Mooney, et al.Journal of Hepatology|May 30, 2012
Nilotinib protects the murine liver from ischemia/reperfusion injuryLee M Ocuin, Shan Zeng, Michael J Cavnar, et al.Journal of the American College of Surgeons|May 21, 2026
Flexibility Stigma and the Double Bind of Family Formation in Medical and Surgical ResidencyMeg C Lovejoy, Ekaterina L Koelliker, Emma A Askew, et al.Annals of Surgical Oncology|May 14, 2026
High-Volume Anesthesiologist and Surgeon Teams are Associated with Lower Operating Room Charges for Cytoreductive Surgery with Hyperthermic Intraperitoneal ChemotherapyYusuf Ciftci, Shannon N Radomski, Victor B Yang, et al.The Journal of Endocrinology|March 12, 2004
N-terminal His(7)-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activityB D Green, M H Mooney, V A Gault, et al.The Journal of Endocrinology|October 27, 2006
Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob miceJ C Parker, K S Lavery, N Irwin, et al.Journal of Applied Clinical Medical Physics|August 3, 2017
Technical note: TROG 15.01 SPARK trial multi-institutional imaging dose measurementKimberley Legge, Peter B Greer, Paul J Keall, et al.Pageof 41